XyloCor Therapeutics logo

XyloCor Therapeutics

Malvern, PA

XyloCor Therapeutics is a development-stage, biotechnology company dedicated to developing first-in-class gene therapies for patients with unmet medical need in cardiovascular disease.

xylocor.com

Company Details

Founded

2013

Employees

Between 10 - 50 employees

Raised

$107,100,000

Headquarters Location

Malvern, PA

Public

No

Acquired

No

CEO

Albert GianchettiAlbert Gianchetti

Founders

Todd Rosengart
Todd Rosengart
Ronald Crystal
Ronald Crystal

Company Collections

These are collections XyloCor Therapeutics is a part of. Click on the collection name to view similar companies.

XyloCor Therapeutics' Industries

XyloCor Therapeutics Headquarters Location

39 Addison Lane, Malvern, PA 19355

Total Amount Raised: $107,100,000

XyloCor Therapeutics Funding Rounds

  • Series B

    $67,500,000

    Series B Investors

    Jeito Capital
    Lumira Ventures
    Life Sciences Partners (LSP)
    Fountain Healthcare Partners

  • Series A

    $22,600,000

    Series A Investors

    Fountain Healthcare Partners
    Lumira Ventures
    Sofinnova Investments
    Life Sciences Partners (LSP)
    Longwood Fund

  • Series A

    $17,000,000

    Series A Investors

    Life Sciences Partners (LSP)
    Sofinnova Investments
Funding info provided by Diffbot.

XyloCor Therapeutics Reviews

0 out of 5 stars

Based on 0 reviews

Review data

Share your thoughts

Worked here? Share your experience. Help others decide if this company is right for them. Write a review on XyloCor Therapeutics.

Recent reviews